NO135939C - - Google Patents

Info

Publication number
NO135939C
NO135939C NO2395/70A NO239570A NO135939C NO 135939 C NO135939 C NO 135939C NO 2395/70 A NO2395/70 A NO 2395/70A NO 239570 A NO239570 A NO 239570A NO 135939 C NO135939 C NO 135939C
Authority
NO
Norway
Application number
NO2395/70A
Other languages
Norwegian (no)
Other versions
NO135939B (fr
Inventor
S A Lee
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB5013069A external-priority patent/GB1260886A/en
Application filed by Ici Ltd filed Critical Ici Ltd
Priority to NO762973A priority Critical patent/NO137124C/no
Publication of NO135939B publication Critical patent/NO135939B/no
Publication of NO135939C publication Critical patent/NO135939C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Monitoring And Testing Of Nuclear Reactors (AREA)
NO2395/70A 1969-06-20 1970-06-19 NO135939C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO762973A NO137124C (no) 1969-06-20 1976-08-30 Fremgangsm}te for fremstilling av morfolinderivater

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB5013069A GB1260886A (en) 1969-06-20 1969-06-20 Process for aryloxymethylmorpholine derivatives
GB3125569 1969-06-20

Publications (2)

Publication Number Publication Date
NO135939B NO135939B (fr) 1977-03-21
NO135939C true NO135939C (fr) 1977-07-06

Family

ID=26260810

Family Applications (1)

Application Number Title Priority Date Filing Date
NO2395/70A NO135939C (fr) 1969-06-20 1970-06-19

Country Status (9)

Country Link
US (1) US3712890A (fr)
JP (1) JPS5016795B1 (fr)
CH (1) CH539068A (fr)
ES (1) ES380973A1 (fr)
FI (1) FI61890C (fr)
HU (1) HU162422B (fr)
NO (1) NO135939C (fr)
SE (1) SE393377B (fr)
YU (2) YU35009B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3857839A (en) * 1969-06-20 1974-12-31 Ici Ltd For cyclising 1-aryloxy-3 beta-substituted ethylamino-2-propanols
GB1427097A (en) * 1973-10-18 1976-03-03 Ici Ltd Optically-active morpholine derivatives
JPS5939437B2 (ja) * 1975-05-08 1984-09-22 ウェルファイド株式会社 モルホリン誘導体の製造法
JPS51146900U (fr) * 1975-05-20 1976-11-25
US4005084A (en) * 1975-07-10 1977-01-25 Yoshitomi Pharmaceutical Industries, Ltd. Thienylmethyl phenoxy morpholine compounds
FR2330383A1 (fr) * 1975-11-06 1977-06-03 Synthelabo Nouveaux ethers de phenols substitues, leurs sels, leur preparation et les medicaments qui les renferment
US4351848A (en) * 1978-03-16 1982-09-28 Drug Science Foundation 1-((1-Methylethyl)amino)-3-(((4-alkylthio)1-naphthalenyl)oxy)-2-propanol
US4342783A (en) * 1980-06-30 1982-08-03 Synthelabo Anti-glaucoma agent
US4396629A (en) * 1980-12-29 1983-08-02 Sterling Drug Inc. Compositions, processes and method
JPS59167545U (ja) * 1983-04-25 1984-11-09 伊藤　秀雄 中高層建築物用人命救助具
CA2522666A1 (fr) * 2003-04-18 2004-10-28 Pharmacia & Upjohn Company Llc Polytherapies
MX2012011821A (es) * 2010-04-12 2012-11-30 Supernus Pharmaceuticals Inc Metodos para producir sales de viloxazina y polimorfos novedosos de las mismas.
US20230295100A1 (en) 2022-03-18 2023-09-21 Supernus Pharmaceuticals, Inc. Process of making derivatives of substituted morpholines
WO2023248154A1 (fr) * 2022-06-22 2023-12-28 Glenmark Life Sciences Limited Procédé de préparation de chlorhydrate de viloxazine
EP4317141A1 (fr) 2022-08-04 2024-02-07 Curia Spain S.A.U. Procédé et intermédiaires pour la préparation de viloxazine et d'autres dérivés de morpholine substitués en 2

Also Published As

Publication number Publication date
SE393377B (sv) 1977-05-09
ES380973A1 (es) 1973-04-16
CH539068A (de) 1973-07-15
FI61890C (fi) 1982-10-11
NO135939B (fr) 1977-03-21
JPS5016795B1 (fr) 1975-06-16
HU162422B (fr) 1973-02-28
US3712890A (en) 1973-01-23
YU268978A (en) 1982-10-31
YU40208B (en) 1985-08-31
FI61890B (fi) 1982-06-30
YU35009B (en) 1980-06-30
YU155370A (en) 1979-12-31

Similar Documents

Publication Publication Date Title
AU465413B2 (fr)
NO135939C (fr)
AU429630B2 (fr)
AU450150B2 (fr)
AU442375B2 (fr)
AU427401B2 (fr)
AU470301B1 (fr)
AU438128B2 (fr)
AU442463B2 (fr)
AU442285B2 (fr)
AU442322B2 (fr)
AU442357B2 (fr)
AU425297B2 (fr)
AU442380B2 (fr)
AT308690B (fr)
AU442535B2 (fr)
AU442538B2 (fr)
AU442554B2 (fr)
AU470661B1 (fr)
AU428074B2 (fr)
AU428129B2 (fr)
AU4540468A (fr)
CS149285B1 (fr)
AU5228269A (fr)
CS148377B1 (fr)